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Summary
 
Early onset increases in oxidative stress and tau pathology
are present in the brain of senescence-accelerated mice
prone (SAMP8). Astrocytes play an essential role, both
in determining the brain’s susceptibility to oxidative
damage and in protecting neurons. In this study, we
examine changes in tau phosphorylation, oxidative stress
and glutamate uptake in primary cultures of cortical
astrocytes from neonatal SAMP8 mice and senescence-
accelerated-resistant mice (SAMR1). We demonstrated an
enhancement of abnormally phosphorylated tau in Ser
 
199
 
and Ser
 
396
 
 in SAMP8 astrocytes compared with that of
SAMR1 control mice. Gsk3β
 
 and Cdk5 kinase activity,
which regulate tau phosphorylation, was also increased
in SAMP8 astrocytes. Inhibition of Gsk3β
 
 by lithium or
Cdk5 by roscovitine reduced tau phosphorylation at Ser
 
396
 
.
Moreover, we detected an increase in radical superoxide
generation, which may be responsible for the correspond-
ing increase in lipoperoxidation and protein oxidation.
We also observed a reduced mitochondrial membrane
potential in SAMP8 mouse astrocytes. Glutamate uptake
in astrocytes is a critical neuroprotective mechanism.
SAMP8 astrocytes showed a decreased glutamate uptake
compared with those of SAMR1 controls. Interestingly,
survival of SAMP8 or SAMR1 neurons cocultured with
SAMP8 astrocytes was significantly reduced. Our results
indicate that alterations in astrocyte cultures from SAMP8
mice are similar to those detected in whole brains of
SAMP8 mice at 1–5 months. Moreover, our findings
suggest that this 
 
in vitro
 
 preparation is suitable for
studying the molecular and cellular processes underlying
early aging in this murine model. In addition, our study
supports the contention that astrocytes play a key role
in neurodegeneration during the aging process.
Key words: Astrocytes; glutamate uptake; neuroprotection;
oxidative stress; senescence-accelerated mice; tau protein.
 
Introduction
 
The senescence-accelerated mouse (SAM) is comprised of a
group of 12 strains developed from selective inbreeding of the
AKR/J strain constructed by Takeda 
 
et
 
 
 
al
 
. (1981). The senescence-
accelerated mouse prone-8 (SAMP8) strain manifests irreversible
advancing senescence with pathological, biochemical and
behavioural alterations, whereas the senescence-accelerated
mice resistant-1 (SAMR1) strain presents a normal aging pattern
(Takeda, 1999). For SAMP8 and SAMR1 strains, the median lifespans
have been reported as 10 and 18.9 months of age, respectively
(Takeda 
 
et
 
 
 
al
 
., 1994). Interestingly, the former exhibits age-
related learning and memory deficits, as well as 
 
β
 
-amyloid-like
deposits in the brain (Flood & Morley, 1998; Chen 
 
et
 
 
 
al
 
., 2004).
Furthermore, increases in hyperphosphorylated tau and
cyclin-dependent kinase 5 (Cdk5) expressions and activation
have also been detected in SAMP8 mice (Canudas 
 
et
 
 
 
al
 
., 2005).
For these reasons, SAMP8 mice are regarded as a suitable rodent
model for studying the molecular mechanisms underlying
cognitive impairment in aged subjects.
The free radical theory of aging contends that oxidative
alterations in biomolecules brought about by reactive oxygen
species (ROS) contribute to cellular dysfunction during aging
(Harman, 1956). Indeed, increasing evidence of elevated oxidative
stress in the aged SAMP8 brain has been reported. Increased
levels of lipoperoxidation, carbonyl proteins and ROS in the
brain of SAMP8 mice have been observed, together with learn-
ing and memory deficits as early as 1–5 months of age (Liu &
Mori, 1993; Sato 
 
et
 
 
 
al
 
., 1996a,b; Kurokawa 
 
et
 
 
 
al
 
., 2001; Yasui
 
et
 
 
 
al
 
., 2002, 2003; Farr 
 
et
 
 
 
al
 
., 2003; Poon 
 
et
 
 
 
al
 
., 2004a; Alvarez-
García 
 
et
 
 
 
al
 
., 2006). In addition, chronic administration of
antioxidants, such as melatonin, 
 
α
 
-lipoic acid, N-acetylcysteine
and acetyl-L-carnitine, to SAMP8 mice not only reduced
oxidative damage to neural lipids and proteins, but also lessened
cognitive deficits (Okatani 
 
et
 
 
 
al
 
., 2002; Yasui 
 
et
 
 
 
al
 
., 2002; Farr
 
et
 
 
 
al
 
., 2003; Poon 
 
et
 
 
 
al
 
., 2005). Decreases in superoxide dis-
mutase, catalase, glutathione reductase and glutathione
peroxidase activities, as well as increases in acyl-CoA oxidase,
which have been detected early in SAMP8 mice (1–12 months)
compared with age-matched SAMR1 controls (Sato 
 
et
 
 
 
al
 
., 1996b;
Kurokawa 
 
et
 
 
 
al
 
., 2001; Okatani 
 
et
 
 
 
al
 
., 2002; Alvarez-García
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et
 
 
 
al
 
., 2006; Sureda 
 
et
 
 
 
al
 
., 2006), may cause elevated genera-
tion of ROS. On the other hand, ROS generated by mitochondria
or from other cell sites not only cause damage to mitochondrial
components and DNA, but also trigger degradative processes
that contribute to the aging process (Cadenas & Davies, 2000;
Manczak 
 
et
 
 
 
al
 
., 2005). In fact, mitochondrial DNA deletions as
well as inefficient mitochondrial hyperactivity were found in the
brain of 4- to 8-week-old SAMP8 mice (Fujibayashi 
 
et
 
 
 
al
 
., 1998;
Nishikawa 
 
et
 
 
 
al
 
., 1998). Differential gene expression profile in
12-month-old SAMP8 hippocampus revealed up-regulation of
cytochrome 
 
c
 
 oxidase subunit I and III from the respiratory chain
(Cheng 
 
et
 
 
 
al
 
., 2006).
Astrocytes play an essential role not only in maintaining
normal brain physiology, but also in the brain’s defence against
oxidative damage (for a review, see Cotrina & Nedergaard, 2002).
Astrocytes possess a great number of antioxidant systems,
including glutathione, glutathione transferase, catalase and
superoxide dismutase enzymes (Makar 
 
et
 
 
 
al
 
., 1994; Dringen
 
et
 
 
 
al
 
., 2000). Although they are able to protect neurons from
hydrogen peroxide (H
 
2
 
O
 
2
 
) toxicity (Deshager 
 
et al
 
., 1996),
astrocytes remain vulnerable to oxidative stress, since they react
to low concentrations of H
 
2
 
O
 
2
 
 generating ROS and lipoperoxidation,
and increasing antioxidant defences (Röhrdanz 
 
et
 
 
 
al
 
., 2001).
Furthermore, astrocytes are primarily responsible for clearing
extracellular glutamate, thereby preventing neuronal excitotoxiciy
(for a review, see Anderson & Swanson, 2000). Thus, alterations
in all these systems during aging may potentially reduce the
neuroprotective capacity of astrocytes, further contributing to
neurodegeneration. In fact, increasing evidence suggests that
astrocytes play a significant role in neuronal aging. Heightened
expression of glial fibrillary acidic protein (GFAP) and S100 
 
β
 
protein have been detected during aging in regions of the mouse
and rat brain (O’Callaghan & Miller, 1991; Kohama 
 
et
 
 
 
al
 
., 1995;
Amenta 
 
et
 
 
 
al
 
., 1998), as well as in mouse and rat cortical astro-
cytes aged in culture (Papadopoulos 
 
et
 
 
 
al
 
., 1998; Gottfried
 
et
 
 
 
al
 
., 2002; Tramontina 
 
et
 
 
 
al
 
., 2002; Pertusa 
 
et
 
 
 
al
 
., 2007).
Superoxide production, lipoperoxidation, protein oxidation, and
iron staining remained elevated in aged astrocyte cultures, even
though antioxidant defences had been maintained or increased
(Papadopoulos 
 
et
 
 
 
al
 
., 1998; Gottfried 
 
et
 
 
 
al
 
., 2002; Klamt 
 
et
 
 
 
al
 
.,
2002; Pertusa 
 
et
 
 
 
al
 
., 2007). Mitochondrial membrane potential
in old astrocytes proved more depolarized than in young astro-
cytes (Lin 
 
et
 
 
 
al
 
., 2006). Furthermore, changes in glial glutamate
uptake have been observed during brain aging (for a review,
see Segovia 
 
et
 
 
 
al
 
., 2001). In aged astrocytes in culture, glutamate
uptake was more vulnerable to inhibition by H
 
2
 
O
 
2 
 
exposition
(Gottfried 
 
et
 
 
 
al
 
., 2002; Pertusa 
 
et
 
 
 
al
 
., 2007). Recent studies
have shown that PC12 cells co-cultured with old astrocytes
were more sensitive to the oxidant 
 
tert
 
-buthyl H
 
2
 
O
 
2
 
 than
those co-cultured with young astrocytes (Lin et al., 2006). In
addition, we have shown that astrocytes aged in vitro have a
reduced ability to maintain neuronal survival (Pertusa et al.,
2007).
Until now, pathological neuronal dysfunction has been
regarded as the main mechanism underlying the cognitive
deficits in SAMP8 mice. However, some evidence suggests that
altered astrocytes contribute to the accelerated senescence
noted in this animal model. Increased astrogliosis and
microgliosis have been reported in the hippocampus and
cerebral cortex of SAMP8 mice (Nomura et al., 1996; Wu et al.,
2005). In addition, D-serine, a glial modulator of nerve cells, is
reportedly involved in the long term potentiation (LTP) dysfunc-
tion recorded in hippocampal slices from 12-month-old SAMP8
(Yang et al., 2005a). The aim of this study was to explore
whether SAMP8 astrocytes exhibit aged-related characteristics
consistent with a possible role in the biochemical and behavi-
oural alterations observed in aged SAMP8 mice. The study was
performed in cortical astrocytes since many senescence-related
biochemical changes of SAMP8 mice have been described in this
brain area, as mentioned above. In SAMP8 astrocytes, we found
hyperphosphorylation in some forms of tau, protein kinase
Gsk3β and Cdk5 activation, and increases in overall oxidative
stress status. Glutamate uptake in primary cultures of cortical
astrocytes from SAMP8 mice was decreased compared to that
from SAMR1 mice. We also explored the neuroprotective capacity
of SAMR1 and SAMP8 astrocytes in co-cultures with cortical
neurons from both strains. Here, we have demonstrated that
SAMP8 astrocytes suffer reduced neuroprotective abilities.
Results
Changes in tau, Gsk3β and Cdk5 protein expression in 
SAMP8 astrocytes
The hyperphosphorylation of tau was evaluated by Western blot
using two phosphorylation-dependent and site-specific antibodies
against tau in SAMR1 and SAMP8 astrocytes. Densitometric
analysis of the immunoblots in SAMP8 astrocytes showed a
statistically significant increase in phosphorylated tau at Ser199/
Ser396 sites compared with SAMR1 controls (Fig. 1). The expression
of two Ser/Thr protein kinases involved in regulating tau phos-
phorylation, Gsk3β and Cdk5, was also determined by Western
blot. We detected a significant increase in phosphorylated
Gsk3β at Tyr216 (active form) and a significant decrease at Ser9
(inactive form) in SAMP8 astrocytes compared with SAMR1
(Fig. 2a). These results indicated activation of Gsk3β kinase in
SAMP8 astrocytes in culture. Figure 3(a) shows that Cdk5
immunoblots in SAMP8 and SAMR1 astrocytes were not signi-
ficantly different, indicating similar Cdk protein expression for
both strains. The induction of Cdk5 kinase activity was deter-
mined using p25/p35 labeling. The expression of p35 was
decreased while that of p25 increased in SAMP8 compared with
SAMR1. The calculated p25/p35 ratio showed increased Cdk5
activity in SAMP8 astrocyte cultures. When SAMP8 astrocyte
cultures were treated for 48 h with 10 mM lithium, a specific
inhibitor of Gsk3β activity, a significant increase and decrease
of phosphorylated Gsk3β at Ser9 and Tau at Ser396, respectively,
was detected (Fig. 2b). Roscovitine (15 μM), a non-specific Cdk5
kinase inhibitor, showed a tendency to decrease the p25/p35
ratio (p = 0.2163) and tau phosphorylation at Ser396 (p = 0.1375)
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in SAMP8 astrocytes (Fig. 3b). Roscovitine effects did not reach
statistical significance due to the high variability found between
samples from different cultures.
Oxidative stress increase and mitochondrial 
membrane potential decrease in SAMP8 astrocytes
Basal levels of superoxide anion radical generated for 1 h in
SAMR1 and SAMP8 astrocytes were determined via a hydro-
ethidium probe. As shown in Fig. 4, SAMP8 cultures produced
significantly more superoxide radical than did those of SAMR1.
No differences were observed between the two strains in terms
of hydroperoxide generation (data not shown). The main source
of superoxide radical production is the mitochondrial electron
transport chain that occurs during normal respiration. Mn-
superoxide dismutase transforms superoxide radical into H2O2,
which may diffuse through the mitochondrial membrane to the
cytoplasm. As H2O2 can be transformed into harmful radicals,
increased generation of these oxidants may cause lipid and
protein oxidation. Figure 5(a) shows significantly increased
production of lipoperoxidation, as measured by malondialdehyde
and 4-hydroxyalkenal accumulation, in SAMP8 astrocytes vs.
SAMR1. Protein carbonyl formation, which is indicative of pro-
tein oxidation and protein damage, was significantly elevated
in SAMP8 compared with those of SAMR1 (Fig. 5b). Enhanced
free radical production may be related to changes in mitochon-
drial membrane potential. Therefore, we measured the accu-
mulation of the fluorescent dye rhodamine 123, which is
dependent on membrane potential, in SAMR1 and SAMP8
astrocyte cultures. SAMP8 astrocytes exhibited a significant
reduction in the basal uptake of rhodamine 123 compared with
SAMR1 astrocytes, indicative of lower mitochondrial membrane
potential in those cultures (Fig. 6).
Fig. 1 Representative immunoblots and densitometry analysis of tau protein 
phosphorylation in SAMR1 and SAMP8 astrocyte cultures. Tau 
phosphorylation was assessed using phosphorylation-dependent antibodies 
anti-tau [pSer199] and anti-tau [pSer396]. Graphs summarize the results from 
five separate experiments. The immunoreactivity levels of each band in the 
SAMR1 and SAMP8 cultures were first normalized to that of the 
corresponding Pan-Tau and then to β-actin. Both phosphorylated protein 
levels were increased in SAMP8 astrocyte cultures. Data were compared using 
the Student’s t-test (*p < 0.05).
Fig. 2 (a) Representative immunoblots and densitometry analysis of Gsk3β 
protein phosphorylation in SAMR1 and SAMP8 astrocyte cultures. Gsk3β 
phosphorylation was assessed using phosphorylation-dependent antibodies 
anti-Gsk3β [pSer9] and anti-Gsk3β [pTyr216]. Graphs summarize the results 
from three to seven separate experiments. The immunoreactivity levels of each 
band in the SAMR1 and SAMP8 cultures were normalized to that of the 
corresponding β-actin. The protein levels of Gsk3β [pTyr216] and Gsk3β [pSer9] 
increased and decreased, respectively, in SAMP8 astrocyte cultures vs. SAMR1. 
(b) Effects of the Gsk3β inhibitor lithium (10 mM, 48 h) on Gsk3β 
phosphorylation at Ser9 and tau phosphorylation at Ser396 in the SAMP8 
astrocyte cultures. Graphs summarize the results from three to four separate 
experiments. The immunoreactivity levels of tau pSer396 were first normalized 
to that of the corresponding Pan-Tau and then to β-actin. Lithium increased 
Gsk3β phosphorylation at Ser9, indicating enzyme activity inhibition, and 
decreased tau phosphorylation at Ser396. Data were compared using the 
Student’s t-test (*p < 0.05, **p < 0.01).
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Decreased glutamate uptake in SAMP8 astrocytes
The ability of astrocytes to uptake glutamate was evaluated in
SAMR1 and SAMP8 cultures using an isotopic method with
several glutamate concentrations. Figure 7(a) shows that gluta-
mate uptake in SAMP8 astrocyte cultures was significantly lesser
than in SAMR1 cultures. Kinetic parameters obtained from
Eadie-Hofstee analysis revealed a statistically significant decrease
in Km (92.78 ± 15.15 μM for SAMP8 and 222.2 ± 42.09 μM for
SAMR1, p < 0.05) and Vmax (10.49 ± 0.67 nmol mg–1 protein min–1
for SAMP8 and 49.99 ± 5.09 nmol mg–1 protein min–1 for SAMR1,
p < 0.0001) values in SAMP8 astrocytes (Fig. 7b). SAMP8 astrocytes
treated with 100 μM trolox or 10 μM curcumin throughout the
culture time period did not undergo a reversal of glutamate
uptake inhibition (Fig. 7c). Expression of the glutamate-aspartate
Fig. 5 Lipoperoxidation and carbonyl proteins in SAMR1 and SAMP8 
astrocyte cultures. Lipoperoxidation (a) was expressed as nmol of 
malondialdehyde plus 4-hydroxyalkenal mg–1 of protein and carbonyl proteins 
(b) were expressed as nmol of protein carbonyl mg–1 of protein. Results 
represent the mean ± SEM of six independent cultures. We observed 
significantly more lipid and protein damage in SAMP8 cultures than in SAMR1 
cultures. *p < 0.05 and **p < 0.0001 compared with SAMR1 astrocytes 
using the Student’s t-test.
Fig. 6 Mitochondrial membrane potential in SAMR1 and SAMP8 astrocyte 
cultures, as measured by the fluorescent dye rhodamine 123 (Rh 123). Results 
are expressed as fluorescence units (FU) of Rh 123 per μg of protein and 
represent the mean ± SEM of three independent cultures. SAMP8 astrocytes 
showed a reduced basal rhodamine 123 uptake. *p < 0.01 compared with 
SAMR1 astrocytes using the Student’s t-test.
Fig. 3 (a) Representative immunoblots and densitometry analysis of Cdk5, 
p35 and p25 proteins in SAMR1 and SAMP8 astrocyte cultures. Graphs 
summarize the results from three to five separate experiments. The 
immunoreactivity levels of each band in the SAMR1 and SAMP8 cultures were 
normalized to that of the corresponding β-actin. SAMP8 and SAMR1 Cdk5 
protein levels were not different. The p25/p35 ratio indicated a decrease in 
p35 band intensity, which resulted in an increase in p25 band intensity in 
SAMP8 astrocytes. (b) Effects of the Cdk5 inhibitor roscovitine (15 μM, 48 h) 
on p35 and p25 proteins and tau phosphorylation at Ser396 in the SAMP8 
astrocyte cultures. Graphs summarize the results from 3–4 separate 
experiments. The immunoreactivity levels of tau pSer396 were first normalized 
to that of the corresponding Pan-Tau and then to β-actin. Roscovitine slightly 
decreased the p25/p35 ratio (p = 0.2163) and tau phosphorylation at Ser396 
(p = 0.1375). Data were compared using the Student’s t-test (*p < 0.05).
Fig. 4 Intracellular superoxide anion radical generation after 1 h in SAMR1 
and SAMP8 astrocyte cultures, as measured by dihydroethidium oxidation to 
ethidium. Results are expressed as nmol of ethidium mg–1 of protein and 
represent the mean ± SEM of three independent cultures. SAMP8 cultures 
generated significantly more superoxide radicals than did SAMR1 cultures. 
*p < 0.01 compared with SAMR1 astrocytes by the Student’s t-test.
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transporter (GLAST) was examined by Western blot and no
changes were observed between SAMP8 and SAMR1 astrocytes
(data not shown).
SAMP8 astrocytes show reduced neuroprotective 
capacity
The neuroprotective capacity of astrocytes was evaluated in co-
cultures with cortical neurons by determining neuronal survival.
Living neurons were identified by staining in co-cultures of
SAMR1 or SAMP8 neurons seeded on a monolayer of either SAMR1
or SAMP8 astrocytes for 12 days. Thereafter, the number of living
cells, either in SAMR1 or SAMP8 neurons, proved to be less in
SAMP8 astrocyte co-cultures than in those of SAMR1 (Fig. 8a).
These results revealed that SAMP8 astrocytes suffered a reduced
neuroprotective capacity. No differences were found in the
number of living neurons from SAMR1 or SAMP8 mice co-
cultured with SAMP8 astrocytes. When SAMR1 and SAMP8
neurons were cultured in the presence of astrocyte-conditioned
medium from SAMR1 or SAMP8 mice, their survival was higher
than in the absence of astrocytes but lower than in co-cultures,
and was similar for both types of astrocytes (Fig. 8b). These results
suggested that differences in neuroprotective capacity are not
due to a soluble compound secreted by astrocytes to the medium.
Taking into account the high astrocyte enrichment of the
cultures, alterations observed in this work were attributed to
the astrocyte population. However, some small contribution of
contaminant microglial cells cannot be discarded.
Discussion
Although mainly present in neuronal cells, tau protein has also
been found in the astrocytes and oligodendrocytes of some
neural diseases (for review, see Avila et al., 2004). It has been
largely demonstrated that the hyperphosphorylation of tau reduces
its binding to microtubules, thereby resulting in neurofibrillary
degeneration. This process occurs systematically in the neurons
of human entorhinal and hippocampal regions during aging
Fig. 7 (a) Glutamate uptake in SAMR1 and 
SAMP8 astrocyte cultures. Astrocytes were 
incubated with 9.8 nM [3H]-glutamate and several 
concentrations of unlabelled glutamate as 
described in the Experimental procedures. Each 
point represents the mean ± SEM of five to eight 
determinations. Two-way analysis of variance 
followed by Bonferroni’s test showed that strain 
(F1,107 = 23.95, p < 0.0001) and glutamate 
concentration (F8,107 = 9.63, p < 0.0001) had a 
significant effect. (b) Values from (a) (glutamate 
uptake and unlabelled glutamate concentrations 
from SAMR1 and SAMP8 astrocytes) were used to 
construct the Eadie-Hofstee representation to 
calculate Km and Vmax kinetic parameters. There 
was a significant decrease in the Km and Vmax 
values of glutamate uptake in SAMP8 astrocyte 
cultures (see Results). (c) Glutamate uptake in 
SAMP8 astrocytes treated during the culture 
period with 100 μM trolox or 10 μM curcumin. No 
significant effects were observed.
Fig. 8 Neuronal survival of SAMR1 and SAMP8 neurons in the presence of 
(a) astrocytes or (b) astrocyte-conditioned medium (ACM) from SAMR1 and 
SAMP8 mice. Cortical neurons were cultured on a monolayer of SAMR1 and 
SAMP8 astrocyte cultures or with 48 h ACM for 12 days. Living neurons in 
both conditions were identified by cell staining using NeuN or NF antibody 
and propidium iodide. Results are expressed as the number of living neurons 
by field and represent the mean ± SEM of seven independent co-cultures. 
Number of astrocytes by field is 230 ± 13 and 237 ± 16 for SAMR1 and SAMP8 
astrocytes, respectively. Data were compared using the Student’s t-test (*p < 0.05, 
**p < 0.01 related to co-cultures of neurons and SAMR1 astrocytes).
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(Delacourte et al., 2002, 2003). Recently, several authors reported
an age-dependent pattern of glial tau aggregation in both
human and baboon brains (Schultz et al., 2000; Yang et al.,
2005b). Previous studies have shown that hyperphosphorylation
of tau occurs in the brain of SAMP8 mice at 5 months of age
(Canudas et al., 2005; Sureda et al., 2006). Consistent with
these data, the present study has demonstrated increased tau
phosphorylation at Ser199 and Ser396 in SAMP8 astrocyte cultures
obtained from neonate brain, as compared with those of
SAMR1 mice. Both sites have been shown to be phosphorylated
in vitro by several protein kinases, such as Cdk5 and Gsk3β (see
the review by Gong et al., 2005). Our results showed an
increase and decrease of the active (pTyr279) and inactive (pSer9)
form, respectively, of Gsk3β in SAMP8 vs. SAMR1, thus indi-
cating activation of this enzyme. In addition, an increase in the
p25/p35 ratio in SAMP8 astrocytes also denoted activation of
the Cdk5 kinase. It is worth noting that the presence of func-
tional Cdk5/p35 in murine cortical astrocyte cultures was
recently reported by He et al. (2007). Therefore, both protein
kinases may be responsible for the hyperphosphorylation of tau
in SAMP8 astrocytes. The increase of Cdk activity was in agree-
ment with the results in early senescent SAMP8 brains reported
in the above-mentioned study of Canudas et al. (2005). On the
other hand, no changes were reported in the phosphorylation
at pTyr279 and pSer9 sites of Gsk3β between SAMP8 and SAMR1
brain. We cannot discard an increase of Gsk3β kinase activity
in the absence of Gsk3β phosphorylation changes in senescent
mice in vivo, according to the findings in old p25 transgenic
mice with constant Cdk5 over-activation (Plattner et al., 2006).
Therefore, in brains of early senescent SAMP8, Gsk3β kinase
activity might be enhanced through Cdk5 activation. If this were
the case, Gsk3β phosphorylation changes in astrocyte cultures
would be indicative of inconsequential differences in the path-
ways of tau hyperphosphorylation as related to the brain tissue.
The hyperphosphorylation of tau in cultures of SAMP8 neonate
astrocytes may be considered as an early signal of an aging-
related pathological process. The biological significance of astrocytic
tau pathology in aging remains largely unknown. In certain
diseases characterized by tau-based neurofibrillary pathology
(tauopathies), tau aggregation in astrocytes appears to have no
link with gliosis and, in fact, has been regarded as a degener-
ative process (Togo & Dickson, 2002). Moreover, a transgenic
mouse model of human tau expression in astrocytes has shown
an age-dependent pathology with abnormal tau phosphorylation
leading to a focal neuron degeneration (Forman et al., 2005).
The regulation of tau hyperphosphorylation at different sites
by protein kinases is a complex mechanism not well known, that
probably requires the synergistic action of two or more kinases
(Sengupta et al., 2006). Li et al. (2006) reported that Cdk5
phosphorylates tau at S404 and enhances Gsk3β-catalysed tau
phosphorylation at S400 and S396, suggesting that Cdk5 primes
tau for Gsk3β in the brain. In our work, tau hyperphosphorylation
at S396 was reduced by lithium and roscovitine, indicating a
directly Gsk3β- and Cdk5-mediated tau hyperphosphorylation
at this site in SAMP8 astrocytes. However, we cannot discard
that Gsk3β-mediated tau hyperphosphorylation at Ser396 in
SAMP8 astrocytes were a consequence of Cdk5-mediated
phosphorylation at other sites in tau, as has been reported by
Li et al. (2006) in rat brain. Further studies are necessary to identify
the precise mechanisms underlying the hyperphosphorylation of
tau in SAMP8 astrocytes.
There is wide consensus that free radicals are involved in the
damaging processes associated with brain aging (Poon et al.,
2004b). Interestingly, there is significant evidence that SAMP8
mice (age 1–5 months) possess a more elevated oxidative status
compared with SAMR1 controls (Liu & Mori, 1993; Sato et al.,
1996a,b; Kurokawa et al., 2001; Yasui et al., 2002, 2003; Farr
et al., 2003; Poon et al., 2004a; Alvarez-García et al., 2006). In
the current study, we demonstrated that SAMP8 astrocyte cul-
tures present increased superoxide radical generation, lipoper-
oxidation and carbonyl proteins vs. SAMR1, which is consistent
with in vivo studies. Elevated oxidative stress and abnormally
phosphorylated tau in SAMP8 astrocytes suggest that neonatal
astrocytes maturated in culture acquire characteristics similar to
those observed in vivo in the brains of senescent SAMP8 mice.
Thus, SAMP8 astrocyte cultures offer an effective model for
studying the molecular and cellular processes underlying aging.
Furthermore, these results support previous hypotheses con-
tending that glial oxidative stress is involved in the aging process.
In this context, several authors have demonstrated increased
superoxide production, lipoperoxidation, protein oxidation and
iron staining in astrocytes aged in culture (Papadopoulos et al.,
1998; Gottfried et al., 2002; Klamt et al., 2002; Pertusa et al.,
2007). It has been proposed that ROS generated by mitochon-
dria accumulate during aging and are not only responsible for
the damage present in mitochondrial components, but also
cause degradative processes (Cadenas & Davis, 2000; Lenaz
et al., 2006). Accordingly, we have detected lower mitochon-
drial membrane potential in SAMP8 astrocytes, which may stem
from the elevated oxidative stress detected in these cultures.
These results are in agreement with studies carried out by Lin
et al. (2006) in which astrocytes cultured from older mice exhibited
lower mitochondrial membrane potential than astrocytes cul-
tured from younger mice. Age-related correlations between
increases in ROS production and decreases in mitochondrial
membrane potential have also been detected in hippocampal
neurons cultured from old rats (Parihar & Brewer, 2007). On
the other hand, our results are in agreement with those authors
who observed altered mitochondrial dysfunction in SAMP8
mice. For instance, Nishikawa et al. (1998) detected an early
stage mechanism underlying the age-associated mitochondrial
dysfunction present in SAMP8 mouse brain, and Xu et al. (2007)
reported that platelet mitochondrial membrane potential as well
as hippocampal and platelet ATP content in SAMP8 mice
decreased at early age compared with SAMR1. Thus, our results
support the contention that mitochondrial alterations may play
a key role in the aging process.
The consequences of tau pathology on astrocyte function
have not been thoroughly investigated. Recently, a transgenic
mouse model used to investigate tau pathology in astrocytes
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revealed some loss of function as a consequence of increased
tau expression and abnormally phosphorylated, ubiquitinated
and filamentous tau (Forman et al., 2005; Dabir et al., 2006).
These transgenic mice manifested neurodegeneration and reduced
glutamate transport in those cerebral regions with robust
astrocytic tau expression. In our own SAMP8 astrocyte cultures,
we also noted decreased glutamate uptake in tandem with the
above-mentioned increases in abnormally phosphorylated tau
and oxidative stress. Alterations in glial glutamate transport may
result from oxidative injury. Trotti et al. (1997) reported that
glutamate transporters are vulnerable to oxidants due to the
fact that they possess a redox regulatory mechanism. We were
unable to reverse the inhibition of glutamate uptake in SAMP8
astrocytes using trolox and curcumin antioxidant treatments,
even though we did reverse H2O2-induced glutamate uptake
inhibition in astrocyte aged in culture (Pertusa et al., 2007). It
is possible that a different antioxidant pattern treatment is
required to reverse long-time oxidative effects. On the other
hand, reduced glutamate uptake in the transgenic mouse of tau
pathology has been associated with a decreased expression of
glial glutamate transporters (Dabir et al., 2006). However, we
could not detect any reduction in GLAST transporter expression
in SAMP8 astrocytes. It has been suggested that alterations in
the trafficking of glutamate transporters by tau pathology may
lead to reduced glutamate uptake (Dabir et al., 2006). Additional
studies are needed to evaluate the functional consequences of
tau alterations in glial glutamate transport.
The role played by astrocytes in neuronal antioxidant defence
is now widely understood (Deshager et al., 1996). Previous studies
have demonstrated that functional alterations in astrocytes aged
in vitro (Pertusa et al., 2007) or in astrocytes cultured from old
mice (Lin et al., 2006) lead to reduced neuronal survival. We
examined the survival of cortical neurons from SAMR1 and SAMP8
mice 12 days after co-culturing with SAMR1 and SAMP8 astro-
cytes. The latter were less able to protect cortical neurons from
both strains than were SAMR1 astrocytes. When SAMR1 and
SAMP8 neurons were cultured with astrocyte-conditioned medium
from SAMR1 or SAMP8 astrocytes, similar neuronal survival was
attained. Therefore, differences in neuroprotective capacity
seem not to be mediated by soluble compounds released from
astrocytes to medium. The attained neuroprotection was lower
than that observed in co-cultures. Accordingly, it is well known
that survival of neurons cultured in conditioned medium from
astrocytes is significantly prolonged in relation to pure neuronal
cultures, but is lower than that obtained when neurons and
astrocytes are co-cultured (Bauer & Tontsch, 1990; Walsh et al.,
1992). This suggests that several cellular mechanisms can underlie
the neuroprotective role of astrocytes in addition to soluble
factors. It can be suggested that alterations in oxidative stress,
mitochondrial function, glutamate uptake and/or tau phospho-
rylation in SAMP8 astrocytes are underlying factors in the lost
of neuroprotection. For instance, reduction in glial glutamate
uptake capacity may elevate extracellular glutamate levels
leading to neuronal excitotoxicity (Rohstein et al., 1996). Thus,
changes in astrocyte function may play a key role in determining
neuronal survival in the aged SAMP8 brain. Indeed, increases
in GFAP expression and PK-11195 binding activity (a marker of
gliosis), together with neurodegeneration, have been reported
in the hippocampus and cerebral cortex of SAMP8 mice (Nomura
et al., 1996; Wu et al., 2005; Sureda et al., 2006). Altered astro-
cytic function may contribute not only to brain neurodegeneration,
but also to the premature learning and memory deficits
observed in this murine model of early aging.
In summary, we have shown that astrocytes cultured from
neonatal SAMP8 mice present similar alterations to those
described in the whole brains of SAMP8 mice at 1–5 months
of age. Similar to what occurs during brain aging, increased ROS
generation in SAMP8 astrocytes can lead to lipid and protein
oxidation, which in turn can cause changes in mitochondrial
activity, tau phosphorylation and glutamate transport. All of
these alterations can compromise astrocyte functionality. In this
context, we have shown that SAMP8 astrocytes have reduced
neuroprotective ability. This finding is in agreement with our
previous studies showing decreased neuroprotection in
astrocytes aged in culture (Pertusa et al., 2007). The present
study demonstrates the dysfunction present in SAMP8 astrocytes
and also supports the hypothesis that age-related alterations in
astrocytes contribute to neurodegeneration.
Experimental procedures
Materials
SAMP8 and SAMR1 mice were provided by Harlan Interfauna
Ibérica (Barcelona, Spain). Dulbecco’s modified Eagle medium
(DMEM), gentamycin and fetal bovine serum (FBS) were purchased
from Gibco-BRL (Invitrogen, Paisley, UK). Culture plates, chamber
slides and flasks were from NUNC (Roskilde, Denmark). L-[3H]-
glutamate (specific activity, 51 Ci mmol–1) was purchased from
PerkinElmer Inc. (Wellesley, MA, USA). The fluorescent probes
2’-7’-dichlorfluorescin diacetate (DCFH-DA), dihydroethidium
and rhodamine-123 were obtained from Molecular Probes
(Leiden, The Netherlands). L-glutamic acid, H2O2, thiazolyl blue
tetrazolium bromide (MTT), trolox, curcumin, roscovitine and
lithium chloride were obtained from Sigma Chemical Co. (St.
Louis, MO, USA). Anti-tau [pSer199], anti-tau [pSer396] and anti-
Pan-Tau antibodies were from Biosource International Inc.
(Camarillo, CA, USA), anti-Cdk5, anti-p35 and anti-p25 from
Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA), anti-
Gsk3β [pTyr216] and anti-Gsk3β [pSer9] from Bioreagents
(Golden, CO, USA), anti-GLAST antibody from Alpha Diagnostic
International (San Antonio, TX, USA), anti-NeuN from Chemi-
con International (Temecula, CA, USA) and anti-neurofilament
(NF) from DAKO (Glostrup, Denmark). All chemicals were of
analytical grade.
Astrocyte cultures
Primary cultures enriched in astrocytes were established using
cerebral cortical tissue from 2-day-old SAMP8 and SAMR1 mice.
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Brains were dissected free of the meninges, diced into small
cubes and dissociated by incubation with a 0.5% trypsin-EDTA
solution (Gibco) for 25 min. Cells were seeded at 0.25 × 106
cells mL–1 (0.75 × 105 cells cm–2) in multiwell plates, chamber
slides or flasks in DMEM supplemented with 2.5 mM glutamine,
100 μg mL–1 gentamycin and 20% FBS at 37 °C in a humidified
atmosphere of 5% CO2/95% air. The culture medium was
changed every 3–4 days and FBS was progressively lowered
to 10% during the first 2 weeks. Experiments were routinely
carried out at 21 days in vitro. Established astrocyte cultures of
both SAMR1 and SAMP8 consisted of 85–90% astrocytes, 10–
15% microglia and 0.1–1% oligodendroglia. Neither cell
death nor morphological alterations were observed in SAMP8
cultures.
Neuronal survival in co-culture with astrocytes
To study the neuronal protective response of SAMR1 and
SAMP8 astrocyte cultures, co-cultures of neurons and astrocytes
were plated on 12-mm coverslips. Fresh neurons disaggregated
from the cerebral cortical tissue of SAMR1 and SAMP8 15-day-
old fetuses were directly seeded at 1.5 × 106 cells mL–1 (4.5 × 105
cells cm–2) on a confluent monolayer of SAMR1 and SAMP8
astrocyte cultures. Cultured medium was DMEM supplemented
with 0.2 mM glutamine, insulin B 100 mU L–1, pABA 7 μM and
10% FBS. Neuronal survival was assessed at 12 DIV. Dead cells
were detected by staining the cultures with 7.5 μM propidium
iodide (red fluorescence) for 30 min. Cultures were subse-
quently washed with PBS and fixed with 4% paraformaldehyde.
Living neurons were identified by immunostaining with NeuN
or NF antibodies. Cells were permeabilized with 0.25% Triton
in PBS for 30 min, washed with PBS, incubated with goat serum
to block unspecific binding sites at room temperature, and
incubated with mouse Neu-N or NF antibodies (diluted 1 : 200)
overnight at 4 °C. Cultures were then washed with PBS and
incubated with anti-mouse Alexa Fluor 488 (green fluorescence)
for 1 h at room temperature. After washing with PBS, nuclei
were stained with 5 μM bisbenzimide. Finally, cultures were
mounted on microscope slides. Randomly chosen fields were
examined using a fluorescence microscope (Nikon Eclipse
E1000, Nikon, Tokyo, Japan) and digitally photographed with
a ColorView camera (Soft Imaging Systems, Stuttgart, Ger-
many). Neuronal survival was determined by counting immuno-
reactive neurons to NeuN or NF that were not propidium iodide
stained, using the ANALYSIS software (Soft Imaging System).
Astrocyte conditioned media were prepared from SAMR1
and SAMP8 astrocyte cultures at 21 DIV. For that purpose, astro-
cyte medium was changed to the neuronal medium used for
co-cultures (see above). Conditioned media were collected after
48 h, centrifuged for 5 min at 300 × g and used immediately.
Neurons were seeded in astrocyte-conditioned media supple-
mented with 30% of fresh neuronal medium to provide a com-
plete nutrient provision. Media were partially changed every
4 days with fresh conditioned media. At 12 DIV, neuronal sur-
vival was measured by the same procedure as in co-cultures.
Reactive oxygen species generation
Intracellular generation of hydroperoxides and superoxide anion
radicals was determined using DCFH-DA and dihydroethidium,
respectively, as previously described (Sebastià et al., 2004).
Briefly, cultures in 96-well plates were washed in HBSS and
loaded with 10 μM DCFH-DA for 20 min at 37 °C. Wells were
then washed with HBSS and basal 2′-7′-dichlorfluorescein
(DCF) fluorescence was measured after 1 h incubation at 37 °C
in a fluorescence plate reader (Spectramax Gemini XS, Mole-
cular Devices, Wokingham, UK) at 485 nm excitation/530 nm
emission. To measure superoxide anion generation, cultures in
96-well plates were loaded with 4.8 μM dihydroethidium and
basal ethidium fluorescence was measured at 485 nm excitation/
590 nm emission after 1 h at 37 °C.
Lipid and protein damage
Lipid peroxidation and protein damage were determined as
described previously (Alvarez-García et al., 2006). Lipid peroxidation
was measured by determining malondialdehyde and 4-hydroxy-
alkenal using a Lipid Peroxidation Assay Kit from Calbiochem
(EMD Biosciences Inc., Darmstadt, Germany). Protein damage
was determined as carbonylated proteins. The chromogene
2,4-dinitrophenylhydrazine reacted with the carbonyl groups of
the damage proteins. Protein carbonyls were determined at
366 nm.
Mitochondrial membrane potential
Changes in mitochondrial membrane potential were measured
using rhodamine 123. Cultures in 96-well plates were incubated
with 13 μM rhodamine 123 at 37 °C for 1 h. The cells were
washed twice with HBSS, and fluorescence was determined at
507 nm excitation/529 nm emission.
Western blot analysis
After shaking the cultures for 4 h to eliminate microglial cells,
the medium was removed and astrocytes were rinsed twice with
PBS. Cells were lysed for 10 min on ice in RIPA buffer (10 mM
PBS, 1% Igepal AC-630, 0.5% sodium deoxycholate, 0.1% sodium
dodecyl sulfate) containing a protease inhibitor cocktail (Com-
plete) and 1 mM orthovanadate. They were then collected and
frozen at –20 °C until assay. Protein extracts were quantified
following the Bradford method. Subsequently, 15 μg of the pro-
tein extracts were denatured at 100 °C for 5 min, loaded onto
a 15% sodium dodecyl sulfate–polyacrylamide gel and electro-
phoresed. Proteins were transferred onto a polyvinylidene dif-
luoride membrane (Immobilon-P, Millipore, Bedford, MA, USA).
This was incubated overnight at 4 °C with the following primary
polyclonal antibodies: anti-tau p[Ser199] and anti-tau p[Ser396]
diluted to 1 : 2000; anti-Gsk3β p[Tyr216], anti-Gsk3β p[Ser9],
anti-Cdk, and anti-p35/p25 diluted to 1 : 1000; anti-GLAST
diluted to 1 : 500. Membranes were incubated for 1 h at room
Reduced neuroprotection by SAMP8 astrocytes, S. García-Matas et al.
© 2008 The Authors
Journal compilation © Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland 2008
638
temperature with horseradish peroxidase-conjugated secondary
antibodies. Proteins were detected with a chemiluminiscence
detection system based on the luminol reaction. Protein loading
of the gels was controlled by staining blots with an antibody
against β-actin (diluted 1 : 10 000). The immunoreactive bands
were digitalized and a densitometry analysis was performed
using Quantity One software (Bio-Rad). The levels of protein
immunoreactivity were normalized to that of β-actin. In some
experiments, SAMP8 astrocytes were treated with 10 mM
lithium and 15 μM roscovitine for 48 h.
Glutamate uptake
Astrocyte glutamate uptake was determined as previously
described (Pertusa et al., 2007). Glutamate culture medium was
removed from 96-well cultures and astrocytes were washed
with warm HEPES-buffered saline solution (HBSS) (136 mM NaCl,
5.4 mM KCl, 1.2 mM CaCl2, 1.4 mM MgCl2, 1.0 mM NaH2PO4
and 10 mM HEPES) containing 9 mM glucose at pH 7.3. Astrocyte
cultures were then incubated for 10 min at 37 °C in HBSS with
9.8 nM (500 nCi mL–1) of [3H]-glutamate and several concentra-
tions of unlabelled glutamate in the range of 1 μM to 1000 μM.
Uptake was terminated by removing the medium and washing
the cells three times with ice-cold HBSS. This was immediately
followed by cell lysis in 0.2 N NaOH. Aliquots were taken for
liquid scintillation counting (with Optiphase ‘Hisafe’ cocktail)
and for Bradford’s protein assay using bovine serum albumin
as the protein standard. Radioactivity was analysed by scintillation
counting in a Wallac 1414 Liquid Scintillation Counter (PerkinElmer).
Statistical analysis
Experiments were performed with astrocytes from three to eight
primary cultures (n for each experiment is indicated in the cor-
responding figure legend). Data were pooled and the results
given as mean ± SEM. Statistical significance (p < 0.05) was
determined by the Student’s t-test and two-way analysis of
variance followed by Bonferroni’s multiple comparison test.
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